Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ConfidenHTTM System Safety and Performance of Diagnostic Electrical Mapping of Renal Nerves in Hypertensive Patients and/or Potential Candidates for a Renal Sympathetic Denervation (RDN) Procedure

NCT02777216 is registered in ClinicalTrials.gov with BlueWind Medical as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02777216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ConfidenHTTM System Safety and Performance of Diagnostic Electrical Mapping of Renal Nerves in Hypertensive Patients and/or Potential Candidates for a Renal Sympathetic Denervation (RDN) Procedure
Lead sponsor
BlueWind Medical
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2016
Completion date
December 31, 2017
Enrollment
20 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.